CN1634404A - Musk poison drawing stagnation resolving plaster - Google Patents

Musk poison drawing stagnation resolving plaster Download PDF

Info

Publication number
CN1634404A
CN1634404A CN 200410086305 CN200410086305A CN1634404A CN 1634404 A CN1634404 A CN 1634404A CN 200410086305 CN200410086305 CN 200410086305 CN 200410086305 A CN200410086305 A CN 200410086305A CN 1634404 A CN1634404 A CN 1634404A
Authority
CN
China
Prior art keywords
plaster
grams
musk
poison
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200410086305
Other languages
Chinese (zh)
Inventor
刘福柱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200410086305 priority Critical patent/CN1634404A/en
Publication of CN1634404A publication Critical patent/CN1634404A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The invention relates to a Chinese medicinal external plaster for treating hepatolienomegaly, hepatitis and cirrhosis, wherein the plaster is prepared from musk, myrrh, dragon's blood resin, ligustrum japonicum, frankincense, and boneol.

Description

Musk poison drawing stagnation resolving plaster
The present invention relates to a kind of treatment hepatosplenomegaly, the Chinese medicine of hepatitis and cirrhotic ascites synthesizes externally applied ointment.
Treat the medicine of hep at present, some oral medicine and injection and intravenous drip drug price costliness, the number patient also has many patients untoward reaction to occur with the back DeGrain, makes patient be difficult to accept.
The purpose of this invention is to provide a kind of treatment hepatosplenomegaly, the Chinese medicine of hepatitis and cirrhotic ascites synthesizes externally applied ointment.
The present invention adopts Moschus, Myrrha, Sanguis Draxonis, Fructus Ligustri Lucidi, Moschus blood circulation promoting and dispersing pathogen accumulation, the Myrrha dissipating blood stasis for subsidence of swelling, and the pain relieving of Sanguis Draxonis clots absorbing, Fructus Ligustri Lucidi nourishing kidney the liver benefiting sets upright that the principle effect of tonify deficiency realizes.
The present invention can make musk poison drawing stagnation resolving plaster treatment hepatosplenomegaly owing to adopt such scheme, and the medicine cost of hepatitis and cirrhotic ascites is low, and the cure rate height has no side effect, and does not recur after healing, and effective percentage can reach more than 90%.
Prescription of the present invention: Moschus 3 grams, Myrrha 50 grams, Sanguis Draxonis 18 grams, Fructus Ligustri Lucidi 20 grams, Olibanum 25 grams, Borneolum Syntheticum 30 grams.
Processing technology of the present invention, above medicine is because Chinese medicine mostly is crude drug, wherein some medicine must pass through specific process of preparing Chinese medicine processing procedure, just can meet the treatment needs, give full play to the effectiveness of medicine, need in the medical material to concoct and do not need to concoct, be combined in one jointly and pound into plaster, be attached to patient's abdominal part, fortnight turns over plaster again to be pounded once, must add the medicine that is sprinkling upon the plaster surface in addition, pasted again 16 days, paste altogether and just may take down in 30 days, plaster is taken down the back recover chemical examination in 60 days effectively, two to three paste complete.

Claims (1)

1. treat hepatosplenomegaly for one kind, the Chinese medicine of hepatitis and cirrhotic ascites synthesizes externally applied ointment, it is characterized in that it is to form with the following raw medicaments in portion by weight thing: Moschus 3 grams, Myrrha 50 grams, Sanguis Draxonis 18 grams, Fructus Ligustri Lucidi 20 grams, Olibanum 25 restrain, Borneolum Syntheticum 30 grams.
CN 200410086305 2004-10-25 2004-10-25 Musk poison drawing stagnation resolving plaster Pending CN1634404A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200410086305 CN1634404A (en) 2004-10-25 2004-10-25 Musk poison drawing stagnation resolving plaster

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200410086305 CN1634404A (en) 2004-10-25 2004-10-25 Musk poison drawing stagnation resolving plaster

Publications (1)

Publication Number Publication Date
CN1634404A true CN1634404A (en) 2005-07-06

Family

ID=34847416

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200410086305 Pending CN1634404A (en) 2004-10-25 2004-10-25 Musk poison drawing stagnation resolving plaster

Country Status (1)

Country Link
CN (1) CN1634404A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104116888A (en) * 2014-08-01 2014-10-29 申洪恩 External plaster for treating liver and spleen diseases and production method of external plaster

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104116888A (en) * 2014-08-01 2014-10-29 申洪恩 External plaster for treating liver and spleen diseases and production method of external plaster

Similar Documents

Publication Publication Date Title
CN102614389B (en) Traditional Chinese medicine patch
CN1092314A (en) Treatment diarrheal Chinese medicine for outer use
CN102078472A (en) Medicament for treating verruca wart
CN1634404A (en) Musk poison drawing stagnation resolving plaster
CN1600333A (en) Painkiller
CN100506253C (en) Collateral-flow-activating external-use medicine of Radix Seu Folium Clematidis Henryi for treating injuries by falls
CN100420476C (en) Collateral-flow-activating external-use medicine of Herba et Radix Inebriantis for treating injuries by falls
CN1231243C (en) Medicinal recipe for treating rheumatalgia and treating method
CN101810668A (en) Toxin drawing plaster
CN101904928A (en) Ointment for treating psoriasis
CN1229118C (en) Bone setting medicine
CN1136864C (en) Chinese medicine for treating mastoproliferation
CN1195538C (en) Fengshitong capsule for curing rheumatalgia
CN108175848B (en) Traditional Chinese medicine composition for treating arthralgia and myalgia, plaster containing traditional Chinese medicine composition and preparation method
CN1236798C (en) External medicine for treating bone tuberculosis
CN1049829C (en) Magnetic medicinal plaster for assuaging pain of person suffering from cancer
CN1298371C (en) Medicine for treating hyperplasia of mammary glands and preparation method thereof
CN1104896A (en) Multifunction medicine for curing trauma
CN1167437C (en) Prescription of medicine for curing heloma and planter wart
CN1273167C (en) Medicine for external application for curing rheumatism and its preparation method
CN1814104A (en) Wind-repellent collateral-flow-activating pain-relieving medicine of Radix seu Folium Lobeliae Seguinit
CN105687630A (en) Angelica sinensis-elephant skin hide sore and ulcer paste and preparation method thereof
CN1899477A (en) Musk ointment for removing toxic substances and removing blood stasis
CN1228059C (en) Bone setting ointment
CN102727699A (en) Externally used drug for treating rheumatic arthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication